Clinical Trial Update: Can Patients With Atrial Fibrillation Safely Discontinue Anticoagulant Therapy After Cardiac Surgery? (ATLAAC) [Phase 4]

View source ↗

Summary

This ClinicalTrials.gov entry describes the ATLAAC Phase 4 study evaluating whether patients with atrial fibrillation can safely discontinue anticoagulant thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Odense University Hospital | Conditions: Atrial Fibrillation, Left Atrial Appendage Absent | Phase 4 | Status: RECRUITING